MAUDE Adverse Event Report: MERZ NORTH AMERICA, INC. COAPTITE INJECTABLE IMPLANT

Catalog Number 8005P10

Device Problem Insufficient Information (3190)

Patient Problem Urinary Tract Infection (2120)

Event Date 10/12/2012

Event Type  Other  

Event Description

A pt (b)(6) was enrolled in (b)(6) study for stress urinary incontinence.On (b)(6) 2011, the pt was injected with 3.0 ml coaptite, lot 1014840.On (b)(6) 2012, the pt developed urinary tract infection reported by a pt.On (b)(6) 2012, the pt was treated with antibiotic ciprofloxacin 500mg every 12 hrs x 7 days.The adverse event resolved on (b)(6) 2012.Per physician, the event was of mild severity and probably not related to coaptite.On (b)(6) 2013, the pt developed urinary tract infection reported by a pt.On (b)(6) 2013, the pt was treated with keflex 250mg qid x 20.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.

Manufacturer Narrative

On (b)(6) 2013, the pt developed urinary tract infection reported by a pt.On (b)(6) 2013 the pt was treated with antibiotic cipro 500mg bid x 7 days.The adverse event resolved on (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.On (b)(6) 2013, the pt developed urinary tract infection identified by urinalysis.On (b)(6) 2013, the pt was treated with antibiotic cefdinir, omnicef 300mg 2 x 7 days and then nightly.Keflex for 6 weeks after cefdinir/omnicef.The adverse event resolved in (b)(6) 2013.Per physician, the event was of mild severity and probably not related to coaptite.At the time of this report, the urinary tract infections have resolved.The device history records for the reported lot were reviewed, all required testing specs were met prior to release, there were no abnormalities noted.

• Brand Name: COAPTITE INJECTABLE IMPLANT
• Type of Device: INJECTABLE IMPLANT
• Manufacturer (Section D): MERZ NORTH AMERICA, INC.; franksville WI
• Manufacturer Contact: r. stemler ; 4133 courtney road, #10; franksville, WI 53126 ; 2628353300
• MDR Report Key: 4223996
• MDR Text Key: 5070752
• Report Number: 2135225-2014-00075
• Device Sequence Number: 1
• Product Code: LNM
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: P040047
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Study,Health Professional,Company Representative
• Reporter Occupation: Physician
• Type of Report: Initial
• Report Date: 10/01/2014

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Operator: Health Professional
• Device Expiration Date: 03/01/2013
• Device Catalogue Number: 8005P10
• Device Lot Number: 1024840
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Initial Date Manufacturer Received: 10/01/2014
• Initial Date FDA Received: 10/29/2014
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 03/01/2010
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Treatment: TOVIAZ - 9 WEEKS IN 2013 (NON-SPECIFIC)
• Patient Outcome(s): Required Intervention
• Patient Age: 62 YR
• Patient Weight: 109